Femke Atsma
-
- Blood donation and transfusion practices 17
- Hematology top 5%
- Iron Metabolism and Disorders 12
- Biochemistry top 5%
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 12
-
- Organ Donation and Transplantation 6
- Palliative Care and End-of-Life Issues 5
-
- Cardiac Imaging and Diagnostics 6
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
-
- Chronic Disease Management Strategies 5
- Co-authors
- Yvonne T. van der SchouwDiederick E. GrobbeeMarie-Louise BartelinkWim de KortI.J.T. VeldhuizenFemmie de VegtEamonn FergusonMathias Prokop
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Femke Atsma
79 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Management of Technology and Innovation 562
- Hematology 285
- Biochemistry 135
- Genetics 230
- Endocrinology, Diabetes and Metabolism 359
Countries citing papers authored by Femke Atsma
This map shows the geographic impact of Femke Atsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femke Atsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femke Atsma more than expected).
Fields of papers citing papers by Femke Atsma
This network shows the impact of papers produced by Femke Atsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femke Atsma. The network helps show where Femke Atsma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Femke Atsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 25 | |
| 13 | 2017 | 12 | |
| 14 | 2017 | 17 | |
| 15 | 2016 | 12 | |
| 16 | 2012 | 58 | |
| 17 | 2011 | 118 | |
| 18 | 2011 | 9 | |
| 19 | ALLO-EXPOSED BLOOD DONORS AND TRANSFUSION-RELATED ACUTE LUNG INJURY | 2010 | 1 |
| 20 | 2009 | 73 |
About Femke Atsma
Femke Atsma is a scholar working on Medical Terminology, Management of Technology and Innovation and Hematology, having authored 85 papers that have together received 2.4k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (17 papers), Iron Metabolism and Disorders (12 papers), Hemoglobinopathies and Related Disorders (12 papers), Organ Donation and Transplantation (6 papers), Cardiac Imaging and Diagnostics (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Chronic Disease Management Strategies (5 papers) and Palliative Care and End-of-Life Issues (5 papers). The work is most often cited by research in Management of Technology and Innovation (562 citations), Hematology (285 citations) and Biochemistry (135 citations). Femke Atsma has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Yvonne T. van der Schouw, Diederick E. Grobbee, Marie-Louise Bartelink, Wim de Kort, I.J.T. Veldhuizen, Femmie de Vegt, Eamonn Ferguson, Mathias Prokop, Michiel L. Bots and Gert P. Westert. Their work appears in journals such as PLoS ONE, Hepatology and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.